François Paris

François Paris

Auto-generated profile, based on publicly available information

François Paris

Université de Nantes, Nantes, France

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2003 in Science
Verified
Journal Article
Closed access
PDF file
MGMonica Garcia-Barros
Monica Garcia-Barros
FPFrancois Paris
Francois Paris
CCCarlos Cordon-Cardo
Carlos Cordon-Cardo
DLDavid Lyden
David Lyden
SRShahin Rafii
Shahin Rafii
RKRichard Kolesnick
Richard Kolesnick
About 50% of cancer patients receive radiation therapy. Here we investigated the hypothesis that tumor response to radiation is determined not only by tumor cell phenotype but also by microvascular sensitivity. MCA/129 fibrosarcomas and B16F1 melanomas grown in apoptosis-resistant acid sphingomyelinase ( asmase )–deficient or Bax -deficient mice displayed markedly reduced baseline microvascular endothelial apoptosis and grew 200 to 400% faster than tumors on wild-type microvasculature. Thus, endothelial apoptosis is a homeostatic factor regulating angiogenesis-dependent tumor growth. Moreover, these tumors exhibited reduced endothelial apoptosis upon irradiation and, unlike tumors in wild-type mice, they were resistant to single-dose radiation up to 20 grays (Gy). These studies indicate that microvascular damage regulates tumor cell response to radiation at the clinically relevant dose range.

13 July 2001 in Science
Verified
Journal Article
Closed access
PDF file
FPFrançois Paris
François Paris
ZFZvi Fuks
Zvi Fuks
AKAnthony Kang
Anthony Kang
PCPaola Capodieci
Paola Capodieci
GJGloria Juan
Gloria Juan
RKRichard Kolesnick
Richard Kolesnick
Gastrointestinal (GI) tract damage by chemotherapy or radiation limits their efficacy in cancer treatment. Radiation has been postulated to target epithelial stem cells within the crypts of Lieberkühn to initiate the lethal GI syndrome. Here, we show in mouse models that microvascular endothelial apoptosis is the primary lesion leading to stem cell dysfunction. Radiation-induced crypt damage, organ failure, and death from the GI syndrome were prevented when endothelial apoptosis was inhibited pharmacologically by intravenous basic fibroblast growth factor (bFGF) or genetically by deletion of the acid sphingomyelinase gene. Endothelial, but not crypt, cells express FGF receptor transcripts, suggesting that the endothelial lesion occurs before crypt stem cell damage in the evolution of the GI syndrome. This study provides a basis for new approaches to prevent radiation damage to the bowel.

1 October 2000 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
YMYutaka Morita
Yutaka Morita
GPGloria I. Perez
Gloria I. Perez
FPFrancois Paris
Francois Paris
SMSilvia R. Miranda
Silvia R. Miranda
DEDesiree Ehleiter
Desiree Ehleiter
JTJonathan L. Tilly
Jonathan L. Tilly

1 April 2021 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
PPPataje G Prasanna
Pataje G Prasanna
DCDeborah E Citrin
Deborah E Citrin
JHJeffrey Hildesheim
Jeffrey Hildesheim
MAMansoor M Ahmed
Mansoor M Ahmed
SVSundar Venkatachalam
Sundar Venkatachalam
CCC Norman Coleman
C Norman Coleman
Cellular senescence is an essential tumor suppressive mechanism that prevents the propagation of oncogenically activated, genetically unstable, and/or damaged cells. Induction of tumor cell senescence is also one of the underlying mechanisms by which cancer therapies exert antitumor activity. However, an increasing body of evidence from preclinical studies demonstrates that radiation and chemotherapy cause accumulation of senescent cells (SnCs) both in tumor and normal tissue. SnCs in tumors can, paradoxically, promote tumor relapse, metastasis, and resistance to therapy, in part, through expression of the senescence-associated secretory phenotype. In addition, SnCs in normal tissue can contribute to certain radiation- and chemotherapy-induced side effects. Because of its multiple roles, cellular senescence could serve as an important target in the fight against cancer. This commentary provides a summary of the discussion at the National Cancer Institute Workshop on Radiation, Senescence, and Cancer (August 10-11, 2020, National Cancer Institute, Bethesda, MD) regarding the current status of senescence research, heterogeneity of therapy-induced senescence, current status of senotherapeutics and molecular biomarkers, a concept of “one-two punch” cancer therapy (consisting of therapeutics to induce tumor cell senescence followed by selective clearance of SnCs), and its integration with personalized adaptive tumor therapy. It also identifies key knowledge gaps and outlines future directions in this emerging field to improve treatment outcomes for cancer patients.

1 June 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ACAida Cremesti
Aida Cremesti
FPFrançois Paris
François Paris
HGHeike Grassmé
Heike Grassmé
NHNils Holler
Nils Holler
JTJurg Tschopp
Jurg Tschopp
RKRichard Kolesnick
Richard Kolesnick
Recent studies suggest that trimerization of Fas is insufficient for apoptosis induction and indicate that super-aggregation of trimerized Fas might be prerequisite. For many cell surface receptors, cross-linking by multivalent ligands or antibodies induces their lateral segregation within the plasma membrane and co-localization into “caps” on one pole of the cell. In this study, we show that capping of Fas is essential for optimal function and that capping is ceramide-dependent. In Jurkat T lymphocytes and in primary cultures of hepatocytes, ceramide elevation was detected as early as 15–30 s and peaked at 1 min after CH-11 and Jo2 anti-Fas antibody treatment, respectively. Capping was detected 30 s after Fas ligation, peaked at 2 min, and was maintained at a lower level for as long as 30 min in both cell types. Ceramide generation appeared essential for capping. Acid sphingomyelinase− /− hepatocytes were defective in Jo2-induced ceramide generation, capping, and apoptosis, and nanomolar concentrations of C16-ceramide restored these events. To further explore the role of ceramide in capping of Fas, we employed FLAG-tagged soluble Fas ligand (sFasL), which binds trimerized Fas but is unable to induce capping or apoptosis in Jurkat cells. Cross-linking of sFasL with M2 anti-FLAG antibody induced both events. Pretreatment of cells with natural C16-ceramide bypassed the necessity for forced antibody cross-linking and enabled sFasL to cap and kill. The presence of intact sphingolipid-enriched membrane domains may be essential for Fas capping since their disruption with cholesterol-depleting agents abrogated capping and prevented apoptosis. These data suggest that capping is a ceramide-dependent event required for optimal Fas signaling in some cells.

29 May 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
ICIsabelle Corre
Isabelle Corre
FPFrançois Paris
François Paris
JHJacques Huot
Jacques Huot
The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells